Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement and Interim Management Statement

9 May 2012 11:00

RNS Number : 9646C
Savills PLC
09 May 2012
 



 

 

9 May 2012

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement and Interim Management Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 20 Grosvenor Hill, Berkeley Square, London W1K 3HQ and provides the following Interim Management Statement (IMS) for the period to 9 May 2012.

 

During the first four months of the year Savills has traded overall in line with our expectations. The first quarter saw the anticipated slower markets in Asia, a robust performance from the UK Residential business and continued strengthening of our US pipeline. The UK Commercial business performed well, particularly in central London. The markets of Continental Europe continue to be weak and, against the backdrop of increasing political and economic uncertainty, transactions are taking longer to complete or being put on hold.

 

London's attractions as an investment location remain firmly established. Fiscal changes announced in this year's budget had a short term effect on transaction volumes in the Prime Residential market in London, but they appear to have substantially recovered. Continued political and economic turbulence in many parts of the world has maintained investor interest in London's prime residential property. Outside London we have seen an increase in the volume of activity in the UK Country market both in terms of new stock and applicants. In the residential markets of Greater China and Singapore transaction volumes have been subdued, as anticipated, at this stage in the year.

 

The acquisition of Gresham Down LLP in January has supported our Commercial transaction business in Prime Central London, which has out-performed our expectations during the period and reduced the impact of relative weakness in commercial markets outside London. In Greater China, particularly in the established markets of Shanghai and Beijing, our commercial transaction advisory pipelines have continued to build strongly, supported by the attention of investors and developers progressively turning to office investment from residential assets. It is too early to call a recovery in Hong Kong, but the banking market has recommenced lending on commercial investment, albeit at relatively modest levels, and this bodes well for our performance in the second half of the year.

 

Globally, our Consultancy and Property Management businesses have continued to deliver strong revenue and profit growth and Cordea Savills, the Group's fund management business, has performed as anticipated. The Group continues to manage a strong balance sheet.

 

We continue to anticipate that our financial performance in 2012 will be weighted towards the second half of the year.

 

For further information, contact:

 

Savills 020 7409 8844

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMGGKLLFGZZG
Date   Source Headline
14th Jan 20217:00 amRNSYear End Trading Update
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20208:59 amRNSNon-executive Director changes
14th Dec 20209:45 amRNSDirector/PDMR Shareholding
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
3rd Nov 20202:26 pmRNSHolding(s) in Company
22nd Oct 20205:41 pmRNSHolding(s) in Company
13th Oct 20205:22 pmRNSDirector/PDMR Shareholding
1st Oct 202010:00 amRNSTotal Voting Rights
14th Sep 202011:05 amRNSDirector/PDMR Shareholding
2nd Sep 202010:41 amRNSHolding(s) in Company
13th Aug 20205:00 pmRNSDirector/PDMR Shareholding
6th Aug 20207:00 amRNSHalf-year Report
4th Aug 20203:22 pmRNSTotal Voting Rights
21st Jul 202010:00 amRNSBlock listing Interim Review
13th Jul 20202:15 pmRNSHolding(s) in Company
13th Jul 202012:26 pmRNSDirector/PDMR Shareholding
6th Jul 202010:13 amRNSHolding(s) in Company
6th Jul 202010:09 amRNSHolding(s) in Company
1st Jul 20204:51 pmRNSDirector/PDMR Shareholding
1st Jul 202010:00 amRNSTotal Voting Rights
30th Jun 20204:52 pmRNSDirector/PDMR Shareholding
25th Jun 202011:27 amRNSResult of AGM
25th Jun 20207:00 amRNSAGM Statement
11th Jun 202011:29 amRNSDirector/PDMR Shareholding
5th Jun 20201:03 pmRNSDirectors Remuneration Policy - Clarification
5th Jun 202012:42 pmRNSDirectors Remuneration Policy - Clarification
1st Jun 20207:00 amRNSTotal Voting Rights
12th May 202012:01 pmRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSTotal Voting Rights
30th Apr 202012:15 pmRNSDisclosure of rights attached to equity shares
28th Apr 20203:53 pmRNSDirector/PDMR Shareholding
16th Apr 202011:56 amRNSDirector/PDMR Shareholding
6th Apr 202012:37 pmRNSAnnual Report and AGM Notice
1st Apr 20207:00 amRNS2020 AGM & 2019 final and supplemental dividends
1st Apr 20207:00 amRNSTotal Voting Rights
20th Mar 20205:33 pmRNSDirector/PDMR Shareholding
20th Mar 20201:40 pmRNSDirector/PDMR Shareholding
13th Mar 20201:43 pmRNSDirector/PDMR Shareholding
12th Mar 20207:00 amRNSAcquisition
12th Mar 20207:00 amRNSFinal Results
11th Mar 20201:12 pmRNSDirector/PDMR Shareholding
26th Feb 202012:58 pmRNSHolding(s) in Company
17th Feb 20203:29 pmRNSBlock listing Interim Review
11th Feb 20205:00 pmRNSDirector/PDMR Shareholding
3rd Feb 202011:00 amRNSTotal Voting Rights
21st Jan 20209:00 amRNSBlock listing Interim Review
13th Jan 202012:04 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSYear end Trading Update
7th Jan 202010:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.